{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:46:57Z","timestamp":1788778017223,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jcin.2018.09.033","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T16:03:16Z","timestamp":1545062596000},"page":"2467-2476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents"],"prefix":"10.1016","volume":"11","author":[{"given":"Maayan","family":"Konigstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Banai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gidon Y.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek Ozgu","family":"Ozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kandzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2018.09.033_bib1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.0000140721.27004.4B","article-title":"Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials","volume":"110","author":"Cutlip","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2018.09.033_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjcard.2006.03.059","article-title":"Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a\u00a0pooled analysis of coronary stent clinical trials)","volume":"98","author":"Lee","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","article-title":"Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era","volume":"154","author":"Iijima","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2018.09.033_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ahj.2012.02.014","article-title":"Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents","volume":"163","author":"Billinger","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2018.09.033_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1479164115592252","article-title":"Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction","volume":"12","author":"De Luca","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jcin.2018.09.033_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2007.10.035","article-title":"Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials","volume":"51","author":"Kirtane","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib8","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","article-title":"Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials","volume":"63","author":"Kedhi","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.117.028885","article-title":"Randomized comparison of ridaforolimus- and zotarolimus-eluting coronary stents in patients with coronary artery disease: primary results from the BIONICS trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)","volume":"136","author":"Kandzari","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib13","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib14","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.99.17.2239","article-title":"Effect of diabetes mellitus on formation of coronary collateral vessels","volume":"99","author":"Abaci","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry","volume":"94","author":"Kip","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/14779072.2014.853615","article-title":"Drug-eluting stent outcomes in diabetes","volume":"12","author":"Bernelli","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jcin.2018.09.033_bib17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.CIR.95.6.1366","article-title":"Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study","volume":"95","author":"Kornowski","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.09.033_bib18","first-page":"591","article-title":"A\u00a0randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study","volume":"72","author":"Chan","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2018.09.033_bib19","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.amjcard.2008.01.040","article-title":"Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study)","volume":"101","author":"Maresta","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.amjcard.2010.12.013","article-title":"Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry","volume":"107","author":"Tada","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib21","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","article-title":"Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era","volume":"121","author":"Pi","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.09.033_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/ehjci\/jet158","article-title":"Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis","volume":"15","author":"Iguchi","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcin.2018.09.033_bib24","doi-asserted-by":"crossref","first-page":"E568","DOI":"10.1152\/ajpendo.00297.2009","article-title":"Vascular actions of insulin with implications for endothelial dysfunction","volume":"297","author":"Potenza","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879818320235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879818320235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:33Z","timestamp":1761847713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879818320235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":24,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1936879818320235"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2018.09.033","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2018.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}